Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Matteo Lambertini

MD, PhD
IRCCS Ospedale Policlinico San Martino

Academic History

Matteo Lambertini, MD, PhD, is an Associate Professor and consultant in medical oncology at the University of Genova, Italy, and the IRCCS Policlinico San Martino Hospital, Genova, Italy. He earned his medical degree from the University of Genova, followed by medical oncology training at the IRCCS Policlinico San Martino Hospital. Dr Lambertini further pursued a PhD at the Université Libre de Bruxelles, Brussels, Belgium.

He is an active member of several boards on fertility preservation in patients with cancer, including those of the European Society of Medical Oncology (ESMO), the European Society of Human Reproduction and Embryology (ESHRE), and the Italian Association of Medical Oncology (AIOM). Dr Lambertini has authored over 280 publications in peer-reviewed journals and book chapters, reflecting his extensive contribution to oncology research.

Speaking on fertility preservation and pregnancy in breast cancer patients

Dr Lambertini research centers on breast cancer, with a particular emphasis on young women facing fertility and pregnancy-related challenges post-diagnosis. He has significantly contributed to elucidating the potential of administering gonadotropin-releasing hormone (GnRH) analogs during chemotherapy as a strategy to preserve ovarian function and fertility in patients with breast cancer. His work has also explored the safety of pregnancy following breast cancer treatment and fertility considerations in BRCA-mutated breast cancer patients. He leads multiple clinical trials investigating the efficacy of GnRH analogs during chemotherapy and assesses the safety of post-treatment pregnancies. Through his work, Dr Lambertini strives to enhance the quality of life for survivors of breast cancer, ensuring family planning remains a viable option post-treatment.